Polypharmacy in Type 2 Diabetes Mellitus: Insights from an Internal Medicine Department.

Elena-Codruța DobricăMihnea-Alexandru GamanMatei-Alexandru CozmaOvidiu Gabriel BratuAnca Pantea StoianCamelia Cristina Diaconu

Published in: Medicina (Kaunas, Lithuania) (2019)

Polypharmacy should be an area of serious concern also in type 2 diabetes mellitus, especially in the elderly. In our study, type 2 diabetes mellitus patients received more drugs than their non-diabetes counterparts and were exposed to more drug-drug and food-drug interactions.

Keyphrases

end stage renal disease
adverse drug
type diabetes
chronic kidney disease
newly diagnosed
ejection fraction
glycemic control
cardiovascular disease
prognostic factors
drug induced
emergency department
middle aged
patient reported outcomes
adipose tissue
skeletal muscle
tertiary care
climate change